SCINAI IMMUNOTHERAPEUTICS LTD. Financial Liabilities At Amortised Cost
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Financial Liabilities At Amortised Cost of ILS 76.67 million as of 2020-09-30, per its 6-K filed 2021-01-28.
Discontinued › Notes
ifrs-full:FinancialLiabilitiesAtAmortisedCost · last filed 2021-01-28
- 2020-09-30: Financial Liabilities At Amortised Cost 76.67M ILS.
- 2020-06-30: Financial Liabilities At Amortised Cost 147.54M ILS.
- 2019-12-31: Financial Liabilities At Amortised Cost 164.36M ILS.
- 2019-09-30: Financial Liabilities At Amortised Cost 132.77M ILS.
| Period end | Financial Liabilities At Amortised Cost |
|---|---|
| 2020-09-30 | 76.67M ILS 6-K · filed 2021-01-28 |
| 2020-06-30 | 147.54M ILS 6-K · filed 2020-10-02 |
| 2019-12-31 | 164.36M ILS 6-K · filed 2021-01-28 |
| 2019-09-30 | 132.77M ILS 6-K · filed 2021-01-28 |
| 2019-06-30 | 142.68M ILS 6-K · filed 2020-10-02 |
| 2018-12-31 | 130.80M ILS 20-F · filed 2020-06-12 |